BECTON DICKINSON & CO — Director's Dealing 2022

Nov 29, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BECTON DICKINSON & CO (BDX)
CIK: 0000010795
Period of Report: 2022-11-26

Reporting Person: Hickey David (EVP & President, Life Sciences)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-11-26	Common Stock	A	1816	$0.0	Acquired	5147	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-11-26	Stock Appreciation Rights	$238.06	A	10975	Acquired	2032-11-26	Common Stock (10975)	Direct
2022-11-26	Rights to Common Stock Under Deferred Compensation Plan	$238.06	A	1125	Acquired		Common Stock (1125)	Direct

Footnotes

F1: Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan.

F2: The stock appreciation rights vest in four annual installments beginning November 26, 2023.

F3: The securities are distributed following termination of the reporting person's employment or on the date or dates specified by the reporting person